Efficacy of Envarsus XR and Digital Health Technology in Reducing Tacrolimus Fluctuation and Frequency of Dose Changes

NCT04711291 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped PI left organization and study not adopted by any other staff.

Conditions

Medication Adherence
Renal Transplant

Interventions

COMBINATION_PRODUCT: Conversion to Envarsus-XR and use of smart phone app, TransMedAx
DRUG: Convert to Envarsus XR once daily

Sponsor

Beth Israel Deaconess Medical Center

Collaborators

[object Object]